SpringWorks Therapeutics Reports Third Quarter 2020 Financial Results and Recent Business Highlights

NEXT STORY
Apollomics, Inc. Receives China Investigational New Drug Approval for APL-102 to Initiate a Phase 1 Study
PREV STORY
iTeos Reports Third Quarter 2020 Financial Results and Provides Business Update
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

HealthLynked Reports First Quarter 2019 Financial Results and Recent Revenue Improvement

author_avatar
NASDAQ Market News

Roche announces full FDA approval for Venclexta combinations for acute myeloid leukaemia

author_avatar
NASDAQ Market News

Epizyme Announces Publication of Tazemetostat Phase 1 Clinical Data in The Lancet Oncology

author_avatar
NASDAQ Market News